The data cutoff date for patients with ROS1‐rearranged NSCLC was June 30, 2018 and for patients with ALK‐rearranged NSCLC was April 13, 2012, with some patients still on treatment. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.